Insulin aspart, recombinant Subcutaneous and Neratinib Maleate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Neratinib Maleate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: neratinib
Brand name: Nerlynx
Synonyms: Neratinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nerlynx
- Insulin aspart, recombinant Subcutaneous-Neruo-K-500
- Insulin aspart, recombinant Subcutaneous-Nesacaine
- Insulin aspart, recombinant Subcutaneous-Nesacaine-MPF
- Insulin aspart, recombinant Subcutaneous-Nesina
- Insulin aspart, recombinant Subcutaneous-Nesiritide
- Neratinib Maleate-Insulin degludec
- Neratinib Maleate-Insulin Degludec (U-100) Prefilled Pens
- Neratinib Maleate-Insulin Degludec (U-100) Vials
- Neratinib Maleate-Insulin Degludec (U-200) Prefilled Pens
- Neratinib Maleate-Insulin degludec and liraglutide
- Neratinib Maleate-Insulin degludec and liraglutide Subcutaneous